Abstract
Understanding how drugs are distributed in perilymph following local applications is important as local drug therapies are increasingly used to treat disorders of the inner ear. The potential contribution of cerebrospinal fluid (CSF) entry to perilymph homeostasis has been controversial for over half a century, largely due to artifactual contamination of collected perilymph samples with CSF. Measures of perilymph flow and of drug distribution following round window niche applications have both suggested a slow, apically directed flow occurs along scala tympani (ST) in the normal, sealed cochlea. In the present study, we have used fluorescein isothiocyanate-dextran as a marker to study perilymph kinetics in guinea pigs. Dextran is lost from perilymph more slowly than other substances so far quantified. Dextran solutions were injected from pipettes sealed into the lateral semicircular canal (SCC), the cochlear apex, or the basal turn of ST. After varying delays, sequential perilymph samples were taken from the cochlear apex or lateral SCC, allowing dextran distribution along the perilymphatic spaces to be quantified. Variability was low and findings were consistent with the injection procedure driving volume flow towards the cochlear aqueduct, and with volume flow during perilymph sampling driven by CSF entry at the aqueduct. The decline of dextran with time in the period between injection and sampling was consistent with both a slow volume influx of CSF (∼30 nL/min) entering the basal turn of ST at the cochlear aqueduct and a CSF-perilymph exchange driven by pressure-driven fluid oscillation across the cochlear aqueduct. Sample data also allowed contributions of other processes, such as communications with adjacent compartments, to be quantified. The study demonstrates that drug kinetics in the basal turn of ST is complex and is influenced by a considerable number of interacting processes.
Similar content being viewed by others
References
Adams J, Merchant S (2012) Cochlear lymphatics. Assoc Res Otolaryngol 35:159 (Abstract)
Altmann F, Waltner JG (1947) The circulation of the labyrinthine fluids. Ann Oto Rhino Laryngo 56:684–708
Altmann F, Waltner JG (1950) Further investigations on the physiology of the labyrinthine fluids. Ann Otol 59:657–686
Axelsson A, Ryan AF (2001) Circulation of the inner ear: I. Comparative study of the vascular anatomy of the mammalian cochlea. In: A.F. Jahn, J. Santos-Sacchi (eds) Physiology of the ear. Singular Press, San Diego, pp 301–320
Böhmer A (1993) Hydrostatic pressure in the inner ear fluid compartments and its effects on inner ear function. Acta Otolaryngol Suppl 507:3–24
Chen Z, Kujawa SG, McKenna MJ, Fiering JO, Mark JMJ, Borenstein JT, Swan EL, Sewell WF (2005) Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Contrl Rel 110:1–19
Décory L, Franke RB, Dancer AL (1990) Measurement of the middle ear transfer function in cat, chinchilla and guinea pig. In: Dallos P, Geisler CD, Matthews JW, Ruggero MA, Steele CR (eds) The mechanics and biophysics of hearing. Springer, Berlin, pp 270–277
Ferrary E, Sterkers 0, Saumon O, Tran Ba Huy P, Amiel C (1987) Facilitated transfer of glucose from blood into perilymph in the rat cochlea. Am J Physiol 253:F59–F65
Gisselsson L (1949) The passage of fluorescein sodium to the labyrinthine fluids. Acta Oto!aryngol (Stockh) 37:268–275
Hara A, Salt AN, Thalmann R (1989) Perilymph composition in scala tympani of the cochlea: influence of cerebrospinal fluid. Hear Res 42:265–272
Hirose K, Hartsock JJ, Johnson S, Santi P, Salt AN (2014) Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph. J Assoc Res Otolaryngol 15:707–719
Kaupp H, Giebel W (1980) Distribution of marked perilymph to the subarachnoid space. Arch Otorhinolaryngal 229:245–253
Kimura RS, Schuknecht HF, Ota CY (1974) Blockage of the cochlear aqueduct. Acta Otolaryngol (Stockh) 77:1–12
Lawrence M, Wolks D, Litton WB (1961) Circulation of the inner ear fluids. Ann Otol 70:753–776
Manni JJ, Kuijpers W (1987) Longitudinal flow of macromolecules in the endolymphatic space of the rat. An autoradiographical study. Hear Res 26:229–237
Mynatt R, Hale SA, Gill RM, Plontke SKR, Salt AN (2006) Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex. J Assoc Res Otolaryngol 7:182–193
Naftalin L, Harrison MS (1958) Circulation of labyrinthine fluids. J Laryngol 72:118–136
Ohyama K, Salt AN, Thalmann R (1988) Volume flow rate of perilymph in the guinea pig cochlea. Hearing Res 35(119):130
Plontke SK, Mynatt R, Gill RM, Salt AN (2007) Concentration gradient along scala tympani following the local application of gentamicin to the round window membrane. Laryngoscope 117:1191–1198
Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN (2008) Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 29:401–406
Rask-Andersen H, Schrott-Fischer A, Pfaller K, Glueckert R (2006) Perilymph/modiolar communication routes in the human cochlea. Ear Hear 27:457–465
Salt AN, DeMott JE (1998) Longitudinal endolymph movements induced by perilymphatic injections. Hear Res 123:137–147
Salt AN, Ma Y (2001) Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 154:88–97
Salt AN, Thalmann R (1989) Rate of longitudinal flow of cochlear endolymph. In: Nadol JB (ed) Ménière’s disease. Kugler, Amsterdam, pp. 69 73
Salt AN, Kellner C, Hale S (2003) Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid. Hear Res 182:24–33
Salt AN, Hartsock JJ, Gill RM, Piu F, Plontke SK (2012) Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal. J Assoc Res Otolaryngol 13(6):771–783
Sewell WF, Borenstein JT, Chen Z, Fiering J, Handzel O, Holmboe M, Kim ES, Kujawa SG, McKenna MJ, Mescher MM, Murphy B, Swan EE, Peppi M, Tao S (2009) Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurootol 14:411–422
Shepherd RK, Colreavy MP (2004) Surface microstructure of the perilymphatic space: implications for cochlear implants and cell- or drug-based therapies. Arch Otolaryngol Head Neck Surg 130:518–523
Steel KP (1999) Perspectives: biomedicine. The benefits of recycling. Science 285:1363–1364
Wit HP, Feijen RA, Albers FW (2003) Cochlear aqueduct flow resistance is not constant during evoked inner ear pressure change in the guinea pig. Hear Res 175:190–199
Yimtae K, Song H, Billings P, Harris JP, Keithley EM (2001) Connection between the inner ear and the lymphatic system. Laryngoscope 111:1631–1635
Acknowledgments
This work was supported by research grant DC01368 from the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH).
Conflict of Interest
The authors have no conflicts of interest with regard to this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salt, A.N., Gill, R.M. & Hartsock, J.J. Perilymph Kinetics of FITC-Dextran Reveals Homeostasis Dominated by the Cochlear Aqueduct and Cerebrospinal Fluid. JARO 16, 357–371 (2015). https://doi.org/10.1007/s10162-015-0512-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10162-015-0512-1